- Home
- COGT vs NAT Comparison
COGT vs NAT Comparison
Compare COGT & NAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- NAT
- Stock Information
- Founded
- COGT 2014
- NAT 1995
- Country
- COGT United States
- NAT Bermuda
- Employees
- COGT N/A
- NAT N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- NAT Marine Transportation
- Sector
- COGT Health Care
- NAT Consumer Discretionary
- Exchange
- COGT Nasdaq
- NAT Nasdaq
- Market Cap
- COGT 545.3M
- NAT 534.5M
- IPO Year
- COGT 2018
- NAT 1997
- Fundamental
- Price
- COGT $4.37
- NAT $2.51
- Analyst Decision
- COGT Buy
- NAT Hold
- Analyst Count
- COGT 7
- NAT 2
- Target Price
- COGT $14.17
- NAT $3.50
- AVG Volume (30 Days)
- COGT 1.7M
- NAT 3.0M
- Earning Date
- COGT 05-06-2025
- NAT 05-28-2025
- Dividend Yield
- COGT N/A
- NAT 13.93%
- EPS Growth
- COGT N/A
- NAT N/A
- EPS
- COGT N/A
- NAT 0.22
- Revenue
- COGT N/A
- NAT $225,096,000.00
- Revenue This Year
- COGT N/A
- NAT $21.35
- Revenue Next Year
- COGT N/A
- NAT $4.61
- P/E Ratio
- COGT N/A
- NAT $11.26
- Revenue Growth
- COGT N/A
- NAT N/A
- 52 Week Low
- COGT $3.72
- NAT $2.13
- 52 Week High
- COGT $12.61
- NAT $4.40
- Technical
- Relative Strength Index (RSI)
- COGT 34.56
- NAT 52.64
- Support Level
- COGT $4.12
- NAT $2.38
- Resistance Level
- COGT $5.09
- NAT $2.44
- Average True Range (ATR)
- COGT 0.54
- NAT 0.11
- MACD
- COGT -0.02
- NAT 0.02
- Stochastic Oscillator
- COGT 23.90
- NAT 92.68
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About NAT Nordic American Tankers Limited
Nordic American Tankers Ltd owns and operates double hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters pursuant to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.